nonoxynol has been researched along with HIV Infections in 129 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.10) | 18.7374 |
1990's | 57 (44.19) | 18.2507 |
2000's | 56 (43.41) | 29.6817 |
2010's | 11 (8.53) | 24.3611 |
2020's | 1 (0.78) | 2.80 |
Authors | Studies |
---|---|
Booth, R; da Silva, CE; Eaton, LA; Patterson, TL; Pitpitan, EV; Smith, LR; Wiginton, JM | 1 |
Bourne, N; Milligan, GN; Motamedi, M; Vargas, G; Vincent, KL; Zhu, Y | 1 |
Archer, DF; Callahan, MM; Chandra, N; Creinin, MD; Dezzutti, CS; Doncel, GF; Fichorova, RN; Hillier, SL; Lai, JJ; Mauck, CK; Schwartz, JL; Weiner, DH | 1 |
Coffey, PS; Kilbourne-Brook, M; Kyamwanga, IT; Turyakira, E | 1 |
D'Andrea, A; Fields, S; Fong, J; Mirsalis, J; Rasoul, B; Shew, K; Song, B; Works, MG; Yiu, Y | 1 |
Aung, WS; Bakshi, RP; Coleman, JS; Fuchs, E; Hendrix, CW; Marzinke, MA; Robinson, J; Spiegel, HML | 1 |
Bisika, T | 2 |
Andresen, DN; Falster, MO; Kaldor, JM; Law, MG; Millwood, IY; Poynten, IM; Van Damme, L | 1 |
Alt, C; D'Andrea, A; Dousman, L; Fujita, N; Harrison, T; Matsukawa, A; Mirsalis, J; Shayesteh, S; Shew, K; Tran, TT | 1 |
Cheshenko, N; Fakioglu, E; Herold, BC; Keller, MJ; Mesquita, PM; Wilson, SS | 1 |
Ariën, KK; Delezay, O; Gali, Y; Praet, M; Temmerman, M; Van den Bergh, R; Vanham, G | 1 |
Herold, BC; Keller, MJ; Madan, RP; Mesquita, PM | 1 |
Cerocchi, OG; Donaghay, MA; Doncel, GF; Joseph, T; Schriver, SD; Zalenskaya, IA | 1 |
Buyze, J; Goetghebeur, E | 1 |
Bao, R; Cao, Y; Chen, Y; Han, C; He, B; Jiang, S; Li, L; Li, Y; Shi, W; Sun, Y; Yan, H; Yang, J; Yang, Y; Zhang, X; Zhang, Y; Zhong, M; Zhou, D | 1 |
Lai, JJ; Mauck, CK; Schwartz, JL; Weiner, DH | 1 |
Turpin, JA | 1 |
James, JS | 2 |
Brown-Peterside, P; Chiasson, MA; Holt, R; Koblin, BA; Marmor, M; Mayer, K; Mwatha, A; Smith, C | 1 |
Idemyor, V | 1 |
Wigersma, L | 1 |
Castro, A; Mendez, F | 1 |
Arya, SC | 1 |
Berman, SM | 1 |
Aiuti, F; Luzi, G; Scala, E | 1 |
Townsend, S | 1 |
Gilmour, E | 1 |
Herndon, N | 1 |
Ramjee, G; Rutherford, GW; Tholandi, M; Wilkinson, D | 1 |
Wilkinson, D | 1 |
Alary, M; Chandeying, V; Ettiègne-Traoré, V; Karim, SS; Laga, M; Mâsse, B; Mukenge-Tshibaka, L; Perriëns, J; Ramjee, G; Rees, H; Sirivongrangson, P; Uaheowitchai, C; Van Damme, L; Vuylsteke, B | 1 |
Trager, RS | 1 |
Ramjee, G; Rutherford, G; Tholandi, M; Wilkinson, D | 1 |
Malone, D; O'Sullivan, B | 1 |
Kilmarx, PH; Paxton, L | 1 |
Buchbinder, S; Colfax, GN; Mansergh, G; Marks, G; Rader, M | 1 |
Barnhart, KT; Dayal, MB; Wheeler, J; Williams, CJ | 1 |
Bentley, M; Bollinger, R; Ghate, M; Joglekar, N; Joshi, S; Mehendale, S; Risbud, A; Shepherd, M; Unni, J | 1 |
Brown, H | 1 |
Bajpai, M; Chandra, N; Doncel, GF; Fichorova, RN; Hsiu, JG; Ratnam, V; Spangler, M | 1 |
Alary, M; Chandeying, V; Ettiègne-Traoré, V; Goetghebeur, E; Ramjee, G; Van Damme, L; Vandebosch, A | 1 |
Elsen, R; Guichard, L; Maguire, RA; Phillips, DM; Sudol, KM; Taylor, CL | 1 |
Brown, JM; Chilongozi, DA; Chirenje, M; Hoffman, IF; Kelly, CW; Kumwenda, NI; Martinson, FE; Padian, NS; Richardson, BA; Rosenberg, ZF; Taha, TE; Welch, JD | 1 |
Van Damme, L | 2 |
Cates, W | 1 |
De Deken, B; Gouws, E; Karim, SA; Ramjee, G; Van Dyck, E; Williams, B | 1 |
Chandra, N; Doncel, GF; Fichorova, RN | 1 |
Low-Beer, N | 1 |
Mantell, JE; Morar, NS; Myer, L; Ramjee, G | 1 |
Jiang, S; Liu, S; Stone, A | 1 |
Moodley, K | 1 |
Cohen, J | 1 |
Wittkowski, KM | 2 |
Elias, C; Heise, LL | 1 |
Voelker, R | 1 |
Stein, ZA | 1 |
Bélec, L; Dragon, MA; Grésenguet, G; Meillet, D; Pillot, J | 1 |
Feldblum, PJ; Weir, SS | 1 |
Potts, M | 1 |
Geraci, E | 1 |
Feldblum, PJ; Kaptue, L; Oliver, RM; Zekeng, L | 1 |
Bourinbaiar, AS; Fruhstorfer, EC | 1 |
Rowe, PM | 1 |
Feldblum, PJ; Hira, SK; Kamanga, J; Mukelabai, G; Thomas, JC; Weir, SS | 1 |
Kreiss, JK; Mandaliya, K; Martin, HL; Ndinya-Achola, J; Nyange, PM; Richardson, BA; Rugamba, D; Stevens, CE | 1 |
Coulibaly, IM; Ettiègne-Traoré, V; Ghys, PD; Greenberg, AE; Laga, M; Mah-bi, G; Maïga, A; N'Krumah, M; Tiémelé, A; Van Damme, L | 1 |
Atisook, R; Boer, K; Dally, L; Karam, M; Laga, M; Lange, JM; Niruthisard, S; Perriens, JH; Van Damme, L | 1 |
Cook, RL; Rosenberg, MJ | 1 |
Flanagan, A; Kitchen, VS; Rosenstein, IJ; Smith, JR; Stafford, MK; Taylor-Robinson, D; Ward, H; Weber, J | 1 |
Dietz, K; Susser, E; Wittkowski, KM | 1 |
Roddy, RE; Ryan, KA; Tamoufé, U; Weir, SS; Wong, EL; Zekeng, L | 1 |
Berger, A | 1 |
Cates, W; Feldblum, PJ; Weir, SS | 1 |
Chen, CL; D'Cruz, OJ; Jan, ST; Shih, MJ; Uckun, FM; Venkatachalam, TK | 1 |
Barditch-Crovo, P; Rocco, L; Trapnell, CB; Witter, FR | 1 |
Abdool Karim, Q; Abdool Karim, SS; Laga, M; Rustomjee, R; Stein, Z | 1 |
Krey, LC; Lee-Huang, S; Lu, L; Schreiber, CA; Sun, Y; Wan, L | 1 |
Buchbinder, S; Celum, CL; Coletti, AS; Fleming, TR; Gross, M; Haggitt, RC; Horton, S; Kelly, CW; Levine, H; Paradise, M; Surawicz, C; Tabet, SR | 1 |
Celum, CL; Chesney, MA; Coletti, AS; Gross, M; Kelly, CW; Tabet, SR | 1 |
Chandeying, V; Laga, M; Perriëns, J; Ramjee, G; Rees, H; Sirivongrangson, P; Van Damme, L | 1 |
Coggins, C | 1 |
Stephenson, J | 1 |
Greenhead, P; Griffin, GE; Hayes, P; Laing, KG; Shattock, RJ; Watts, PS | 1 |
Alary, M; Chandeying, V; Ettiègne-Traoré, V; Karim, SA; Morar, NS; Mukenge-Tshibaka, L; Ramjee, G; Van Damme, L; Vuylsteke, B | 1 |
Forbes, A | 1 |
Forbes, A; Heise, L | 1 |
Anderson, DJ; Fichorova, RN; Tucker, LD | 1 |
Almond, N; Darbyshire, J; Jeffries, D; Kitchen, V; McCormack, S; Nunn, A; O'Connor, T; Stone, A; Stott, J; Weber, J | 1 |
Gómez, CA; Halkitis, PN; Parsons, JT; Wolitski, RJ | 1 |
Salyer, D | 1 |
Voeller, B | 1 |
Gollub, EL; Stein, Z | 1 |
Bird, KD | 1 |
Johnson, GK; Nolan, T; Robinson, WS; Wuh, HC | 1 |
Carpel, CG | 1 |
Petersen, CS; Trap, B; Trap, R | 1 |
Newmeyer, JA | 1 |
Raab, VW | 1 |
11 review(s) available for nonoxynol and HIV Infections
Article | Year |
---|---|
The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies.
Topics: Administration, Intravaginal; Anti-HIV Agents; Anti-Infective Agents; Female; Genital Diseases, Female; HIV Infections; Humans; Nonoxynol; Randomized Controlled Trials as Topic; Research Design; Sexually Transmitted Diseases; Vaginosis, Bacterial | 2009 |
Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
Topics: Anti-Infective Agents, Local; Female; Genitalia, Female; HIV Infections; Humans; Immunity, Mucosal; Nonoxynol; Semen; Sexually Transmitted Diseases | 2011 |
Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.
Topics: Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; HIV Infections; HIV-1; Humans; Male; Nonoxynol; Sexually Transmitted Diseases, Viral; Spermatocidal Agents; Treatment Failure | 2002 |
Promising microbicide approach for prevention of human immunodeficiency virus transmission needs more support.
Topics: Administration, Intravaginal; Anti-Infective Agents, Local; Condoms, Female; Female; Gels; HIV; HIV Infections; Humans; International Cooperation; Nonoxynol; Sexually Transmitted Diseases, Viral | 2002 |
Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women.
Topics: Adult; Anti-Infective Agents; Female; HIV Infections; Humans; Nonoxynol; Randomized Controlled Trials as Topic; Sexually Transmitted Diseases; Spermatocidal Agents | 2002 |
Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men.
Topics: Coitus; Female; HIV Infections; Humans; Male; Nonoxynol; Randomized Controlled Trials as Topic; Spermatocidal Agents | 2002 |
Clinical microbicide research: an overview.
Topics: Administration, Intravaginal; Anti-HIV Agents; Female; HIV Infections; Humans; Nonoxynol; Randomized Controlled Trials as Topic; Sexual Behavior; Spermatocidal Agents | 2004 |
Review of non-hormonal contraception (condoms, intrauterine devices, nonoxynol-9 and combos) on HIV acquisition.
Topics: Condoms; Condoms, Female; Contraception; Contraceptive Devices, Female; Female; HIV Infections; Humans; Intrauterine Devices; Male; Nonoxynol; Pregnancy; Pregnancy Complications, Infectious; Sexual Behavior; Spermatocidal Agents | 2005 |
Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? A meta-analysis.
Topics: Chlamydia Infections; Female; Gonorrhea; HIV Infections; Humans; Male; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents | 1998 |
What's up with nonoxynol-9?
Topics: Anti-Infective Agents; Female; HIV Infections; Humans; Nonoxynol; Randomized Controlled Trials as Topic; Sex Work; Sexually Transmitted Diseases; Spermatocidal Agents | 2000 |
[How can a female protect herself from HIV infection?].
Topics: Female; HIV Infections; Humans; Nonoxynol; Polyethylene Glycols; Risk Factors; Sexual Partners; Spermatocidal Agents | 1989 |
20 trial(s) available for nonoxynol and HIV Infections
Article | Year |
---|---|
Injection Drug Use and Sexual Risk Behaviors Among People who Inject Drugs in Ukraine: A Random-Intercept Latent Transition Analysis.
Topics: Drug Users; HIV Infections; Humans; Nonoxynol; Risk-Taking; Sexual Behavior; Substance Abuse, Intravenous; Ukraine | 2023 |
Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure.
Topics: Adult; Anti-Infective Agents; Biomarkers; Cellulose; Double-Blind Method; Female; HIV Infections; Humans; Middle Aged; Nonoxynol; Placebos; Treatment Failure; Vagina; Vaginitis; Young Adult | 2013 |
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.
Topics: Adult; Chlamydia trachomatis; Female; Gels; HIV Infections; HIV-1; Humans; Male; Neisseria gonorrhoeae; Nonoxynol; Sex Work; Spermatocidal Agents | 2002 |
Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India.
Topics: Administration, Intravaginal; Anti-Infective Agents; Colposcopy; Female; HIV Infections; HIV Seronegativity; Humans; India; Nonoxynol; Pessaries; Risk Factors | 2003 |
Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities.
Topics: Administration, Intravaginal; Africa; Asia; Female; HIV Infections; Humans; Nonoxynol; Patient Satisfaction; Sex Work; Spermatocidal Agents; Treatment Outcome; Vaginal Creams, Foams, and Jellies | 2004 |
Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa.
Topics: Administration, Intravaginal; Adult; Developing Countries; Double-Blind Method; Female; Gels; HIV Infections; Humans; Malawi; Mucous Membrane; Nonoxynol; Spermatocidal Agents; Statistics, Nonparametric; Ulcer; Vagina; Vaginal Diseases; Zimbabwe | 2004 |
The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa.
Topics: Adolescent; Adult; Anti-Infective Agents; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seropositivity; HIV-1; Humans; Middle Aged; Nonoxynol; Proportional Hazards Models; Risk Factors; Sex Work; South Africa; Time Factors; Vaginal Creams, Foams, and Jellies | 2005 |
The role of biopsy in vaginal microbicide development.
Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Infective Agents; Biopsy; Colposcopy; Dextrins; Double-Blind Method; Female; HIV Infections; Humans; Inflammation; Middle Aged; Naphthalenesulfonates; Nonoxynol; Polymers; Vagina | 2004 |
Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
Topics: Adolescent; Adult; Aged; Blotting, Western; Coitus; Condoms; Enzyme-Linked Immunosorbent Assay; Female; HIV; HIV Antibodies; HIV Infections; HIV Seronegativity; Humans; Incidence; Male; Middle Aged; Nonoxynol; Sexual Behavior; Sexual Partners; Spermatocidal Agents; Zambia | 1997 |
Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial.
Topics: Adult; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Female; Gels; HIV Infections; Humans; Kenya; Mucous Membrane; Nonoxynol; Sex Work; Sexually Transmitted Diseases; Spermatocidal Agents; Vagina | 1997 |
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.
Topics: Adult; Anti-HIV Agents; Colposcopy; Double-Blind Method; Female; HIV; HIV Infections; Humans; Middle Aged; Nonoxynol; Spermatocidal Agents; Treatment Outcome; Vaginal Discharge; Vaginal Diseases | 1998 |
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
Topics: Administration, Intravaginal; Adult; Biopsy; Colposcopy; Double-Blind Method; Female; Gels; HIV Infections; Humans; Lactobacillus; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents; Surface-Active Agents; Vagina | 1998 |
A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
Topics: Adult; Anti-Infective Agents; Chlamydia Infections; Condoms; Confounding Factors, Epidemiologic; Double-Blind Method; Female; Genital Diseases, Female; Gonorrhea; HIV Infections; Humans; Male; Nonoxynol; Proportional Hazards Models; Sex Work; Sexually Transmitted Diseases; Spermatocidal Agents | 1998 |
Vaginal viricides-another way to tackle HIV transmission.
Topics: Administration, Intravaginal; Antiviral Agents; Female; Gels; HIV Infections; Humans; Nonoxynol; Spermatocidal Agents | 1998 |
Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives.
Topics: Administration, Intravaginal; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Middle Aged; Nonoxynol; Spermatocidal Agents; Treatment Outcome; Vagina; Vaginal Creams, Foams, and Jellies | 1999 |
Phase 1 trial of nonoxynol-9 film among sex workers in South Africa.
Topics: Administration, Intravaginal; Adult; Cross-Over Studies; Double-Blind Method; Female; Genital Diseases, Female; HIV; HIV Infections; Humans; Nonoxynol; Polymerase Chain Reaction; Sex Work; Sexually Transmitted Diseases; South Africa; Spermatocidal Agents; Vagina; Viral Load | 1999 |
Safety and toxicity of nonoxynol-9 gel as a rectal microbicide.
Topics: Adult; Anti-Infective Agents; Epithelium; HIV Infections; Homosexuality, Male; Humans; Intestinal Mucosa; Male; Middle Aged; Nonoxynol; Penis; Rectum; Sexually Transmitted Diseases | 1999 |
Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide.
Topics: Adult; Anti-Infective Agents; HIV Infections; Homosexuality, Male; Humans; Male; Middle Aged; Nonoxynol; Patient Compliance; Rectum; Sexual Behavior; Surveys and Questionnaires | 1999 |
Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.
Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Colposcopy; Condoms; Female; HIV Infections; Humans; Male; Nonoxynol; Placebos; Sex Work; Sexually Transmitted Diseases; Vaginal Creams, Foams, and Jellies | 2000 |
Trial shows Nonoxynol 9 efficacy is questionable.
Topics: Anti-Infective Agents; Condoms; HIV Infections; Humans; Nonoxynol; Placebos; Randomized Controlled Trials as Topic; Sex Work; Sexually Transmitted Diseases; Spermatocidal Agents | 1998 |
98 other study(ies) available for nonoxynol and HIV Infections
Article | Year |
---|---|
Evaluation of immunological markers of ovine vaginal irritation: Implications for preclinical assessment of non-vaccine HIV preventive agents.
Topics: Animals; Anti-Infective Agents; Biomarkers; Cattle; Cellular Microenvironment; Disease Models, Animal; Drug Evaluation, Preclinical; Epithelium; Female; HIV Infections; HIV-1; Humans; Immunophenotyping; Inflammation Mediators; Interleukin-1beta; Interleukin-8; Leukocytes; Nonoxynol; Vagina; Vaginitis | 2017 |
Potential for revitalisation of the diaphragm for family planning in Uganda: a rapid assessment of the feasibility of introducing the SILCS Diaphragm.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Family Planning Services; Female; Focus Groups; HIV Infections; Humans; Male; Nonoxynol; Uganda | 2014 |
New candidate biomarkers in the female genital tract to evaluate microbicide toxicity.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents; Benzalkonium Compounds; Biomarkers; Cellulose; Cytokines; Female; Gene Expression Regulation; Genitalia, Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Mice; Mucin-5B; Nonoxynol; Rabbits; Vagina | 2014 |
Feasibility of radiolabeled small molecule permeability as a quantitative measure of microbicide candidate toxicity.
Topics: Adolescent; Adult; Anti-Infective Agents; Cell Membrane Permeability; Cellulose; Female; Gels; Glycerol; HIV Infections; Humans; Middle Aged; Nonoxynol; Phosphates; Propylene Glycols; Prospective Studies; Technetium Tc 99m Pentetate; Vagina; Vaginal Creams, Foams, and Jellies | 2016 |
FDA requires HIV warning on popular contraceptives.
Topics: Contraceptive Agents, Female; Drug Labeling; HIV Infections; Humans; Nonoxynol; United States | 2008 |
Potential acceptability of microbicides in HIV prevention in stable marital relationships in Malawi.
Topics: Adolescent; Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Malawi; Male; Marital Status; Middle Aged; Nonoxynol; Spermatocidal Agents; Women's Rights; Young Adult | 2009 |
Increased CCL2 expression and macrophage/monocyte migration during microbicide-induced vaginal irritation.
Topics: Animals; Benzalkonium Compounds; Biomarkers; Cell Movement; Chemokine CCL2; Female; HIV; HIV Infections; Humans; Inflammation; Interleukin-1beta; Interleukin-8; Macrophages; Monocytes; Nonoxynol; Rabbits; Surface-Active Agents; Vagina | 2009 |
Female controlled methods of contraception and sexually transmitted infections including HIV in Malawi: examining the role of the female condom and microbicides.
Topics: Anti-Infective Agents; Condoms, Female; Contraception, Barrier; Female; Focus Groups; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Malawi; Male; Nonoxynol; Qualitative Research; Sexually Transmitted Diseases; Spermatocidal Agents; Vaginal Creams, Foams, and Jellies | 2009 |
Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.
Topics: Adenine; Administration, Intravaginal; Animals; Anti-Infective Agents; Antiviral Agents; Biomarkers; Disease Models, Animal; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Mice; Mice, Inbred BALB C; Naphthalenesulfonates; Nonoxynol; Organophosphonates; Polymers; Predictive Value of Tests; Risk Assessment; Tenofovir | 2009 |
Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity.
Topics: Anti-HIV Agents; Cell Culture Techniques; Cell Line; Cervix Uteri; Chemokine CCL2; Chemokine CCL20; Coculture Techniques; Endometrium; Epithelial Cells; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Interleukin-8; Leukocytes, Mononuclear; Models, Biological; Nonoxynol; Organ Specificity; Secretory Leukocyte Peptidase Inhibitor; Uterus; Vagina; Virus Replication | 2010 |
Increased COX-2 expression in human vaginal epithelial cells exposed to nonoxynol-9, a vaginal contraceptive microbicide that failed to protect women from HIV-1 infection.
Topics: Anti-Infective Agents; Cell Line, Transformed; Contraceptive Agents, Female; Cyclooxygenase 2; Dinoprostone; Epithelial Cells; Female; HIV Infections; HIV-1; Humans; Immunity, Mucosal; Inflammation; NF-kappa B; Nonoxynol; Oligonucleotide Array Sequence Analysis; Vagina; Virulence | 2011 |
Crossover studies with survival outcomes.
Topics: Cellulose; Cross-Over Studies; HIV Infections; Humans; Models, Theoretical; Nonoxynol; Survival Analysis | 2013 |
L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicide.
Topics: Adenine; Animals; Anti-Infective Agents; Benzalkonium Compounds; Biomarkers; Carboxymethylcellulose Sodium; Cervix Uteri; Chemokine CCL2; Female; HIV Infections; Inflammation; Interleukin-6; L-Selectin; Mice; Mice, Inbred C57BL; Mucous Membrane; Nonoxynol; Organophosphonates; P-Selectin; Sodium Dodecyl Sulfate; Tenofovir | 2012 |
Colposcopy: still useful in microbicide safety trials?
Topics: Administration, Intravaginal; Anti-Infective Agents; Colposcopy; Drug Resistance, Viral; Female; Guidelines as Topic; HIV Infections; Humans; Male; Nonoxynol; Observer Variation; Surface-Active Agents; Treatment Outcome; Vagina | 2012 |
Nonoxynol-9 harmful, should not be used in condoms, lube.
Topics: Condoms; HIV Infections; Humans; Lubrication; Nonoxynol | 2002 |
Douching practices among women at high risk of HIV infection in the United States: implications for microbicide testing and use.
Topics: Administration, Intravaginal; Adolescent; Adult; Clinical Trials as Topic; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Nonoxynol; Research Design; Risk Factors; Sexually Transmitted Diseases; Spermatocidal Agents; Therapeutic Irrigation; United States | 2002 |
Barrier methods may offer some protection against AIDS.
Topics: Acquired Immunodeficiency Syndrome; Behavior; Condoms; Contraception; Contraceptive Agents; Disease; Family Planning Services; HIV Infections; Infections; Nonoxynol; Sexual Behavior; Sexually Transmitted Diseases; Spermatocidal Agents; Virus Diseases | 1987 |
[Whom the condom fits: mechanical and mental barriers].
Topics: Alcohols; Behavior; Chemical Phenomena; Chemistry; Condoms; Contraception; Contraceptive Agents; Disease; Evaluation Studies as Topic; Family Planning Services; HIV Infections; Nonoxynol; Organic Chemicals; Patient Compliance; Personal Satisfaction; Psychology; Spermatocidal Agents; Virus Diseases | 1988 |
Prevention of sexual transmission of AIDS / STD by a spermicide containing benzalkonium chloride.
Topics: Acquired Immunodeficiency Syndrome; Alcohols; Chemical Phenomena; Chemistry; Clinical Laboratory Techniques; Condoms; Contraception; Contraceptive Agents; Diagnosis; Disease; Family Planning Services; HIV Infections; In Vitro Techniques; Infections; Nonoxynol; Organic Chemicals; Research; Sexually Transmitted Diseases; Spermatocidal Agents; Virus Diseases | 1990 |
AIDS: the plateau?
Topics: Acquired Immunodeficiency Syndrome; Asia; Behavior; Condoms; Contraception; Contraceptive Agents; Developing Countries; Disease; Evaluation Studies as Topic; Family Planning Services; HIV Infections; India; Infections; Nonoxynol; Pharmaceutical Preparations; Research; Sexual Behavior; Sexually Transmitted Diseases; Spermatocidal Agents; Statistics as Topic; Syphilis; Therapeutics; Virus Diseases | 1991 |
Fertility control and HIV infection.
Topics: Africa; Africa South of the Sahara; Africa, Eastern; Behavior; Condoms; Contraception; Contraceptive Agents; Contraceptives, Oral; Demography; Developed Countries; Developing Countries; Disease; Europe; Family Planning Services; Fertility; HIV Infections; Italy; Kenya; Nonoxynol; Population; Population Dynamics; Sexual Behavior; Spermatocidal Agents; Virus Diseases | 1991 |
[The correct use of the condom reduces the risk of HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Behavior; Biology; Condoms; Contraception; Contraceptive Agents; Developed Countries; Disease; Europe; Evaluation Studies as Topic; Family Planning Services; HIV Infections; Italy; Nonoxynol; Risk Factors; Sexual Behavior; Spermatocidal Agents; Virus Diseases | 1989 |
FHI study examines N-9 film effect on STDs. Contraceptive update.
Topics: Africa; Africa South of the Sahara; Africa, Northern; Behavior; Cameroon; Case-Control Studies; Condoms; Contraception; Contraceptive Agents; Developing Countries; Disease; Family Planning Services; HIV Infections; Infections; Nonoxynol; Research; Sexual Behavior; Sexually Transmitted Diseases; Spermatocidal Agents; Virus Diseases | 1997 |
N-9 contraceptive film and the risk of STDs.
Topics: Africa; Africa South of the Sahara; Africa, Northern; Biology; Cameroon; Contraception; Contraceptive Agents; Developing Countries; Disease; Family Planning Services; HIV Infections; Infections; Nonoxynol; Risk Factors; Sexually Transmitted Diseases; Spermatocidal Agents; Virus Diseases | 1997 |
Selected research involving N-9 and STDs.
Topics: Acquired Immunodeficiency Syndrome; Bibliographies as Topic; Contraception; Contraceptive Agents; Disease; Family Planning Services; HIV Infections; Infections; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents; Virus Diseases | 1997 |
OTC spermicides: how helpful in STD prevention?
Topics: Americas; Consumer Product Safety; Contraception; Contraceptive Agents; Developed Countries; Disease; Family Planning Services; Government Agencies; HIV Infections; Infections; Knowledge; Nonoxynol; North America; Organizations; Sexually Transmitted Diseases; Spermatocidal Agents; United States; United States Food and Drug Administration; United States Public Health Service; Vagina; Virus Diseases | 1997 |
The dual goals of reproductive health.
Topics: Acquired Immunodeficiency Syndrome; Condoms; Condoms, Female; Contraception; Contraceptive Agents; Demography; Disease; Family Planning Services; Fertility; Goals; Health; Health Planning; HIV Infections; Infections; Nonoxynol; Organization and Administration; Population; Population Dynamics; Pregnancy; Reproductive Medicine; Sexual Behavior; Sexually Transmitted Diseases; Spermatocidal Agents; Virus Diseases | 1996 |
International award received recognizing anti-HIV spermicide.
Topics: Acquired Immunodeficiency Syndrome; Americas; Contraception; Contraceptive Agents; Developed Countries; Disease; Economics; Family Planning Services; HIV Infections; Minnesota; Nonoxynol; North America; Research; Spermatocidal Agents; Technology; United States; Virus Diseases | 1998 |
Scientists look to chemical barrier methods for women. Sexually transmitted disease (microbicides).
Topics: Acquired Immunodeficiency Syndrome; Americas; Contraception; Contraceptive Agents; Developed Countries; Disease; Family Planning Services; HIV Infections; Infections; Nonoxynol; North America; Research; Sexually Transmitted Diseases; Spermatocidal Agents; United States; Virus Diseases | 1996 |
Spermicide film does not halt AIDS, study finds.
Topics: Acquired Immunodeficiency Syndrome; Africa; Africa South of the Sahara; Africa, Northern; Behavior; Cameroon; Contraception; Contraceptive Agents; Developing Countries; Disease; Family Planning Services; Health Behavior; HIV Infections; Infections; Nonoxynol; Sexual Behavior; Sexually Transmitted Diseases; Spermatocidal Agents; Virus Diseases | 1997 |
Vaginal microbicides needed for female-controlled prevention.
Topics: Acquired Immunodeficiency Syndrome; Contraception; Contraceptive Agents; Disease; Economics; Family Planning Services; Health Services Needs and Demand; HIV Infections; Nonoxynol; Spermatocidal Agents; Vagina; Vaginitis; Virus Diseases | 1999 |
Seeking HIV prevention strategies for women.
Topics: Acquired Immunodeficiency Syndrome; Behavior; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Devices, Female; Disease; Economics; Family Planning Services; Health; HIV Infections; Nonoxynol; Reproductive Medicine; Social Behavior; Socioeconomic Factors; Spermatocidal Agents; Virus Diseases; Women's Rights | 1993 |
Nonoxyl-9 and women's struggle against HIV.
Topics: Acquired Immunodeficiency Syndrome; Contraception; Contraceptive Agents; Disease; Family Planning Services; HIV Infections; Infections; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents; Vaginal Creams, Foams, and Jellies; Virus Diseases | 1996 |
Scientists search for HIV prevention methods women can control.
Topics: Acquired Immunodeficiency Syndrome; Contraception; Contraceptive Agents; Disease; Family Planning Services; HIV Infections; Infections; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents; Virus Diseases | 1995 |
Nonoxynol-9 fails to prevents STDs, but microbicide research continues.
Topics: HIV Infections; Humans; Nonoxynol; Sexually Transmitted Diseases | 2002 |
Nonoxynol-9 dangers: health experts warn against rectal use.
Topics: Condoms; HIV Infections; Homosexuality, Male; Humans; Lubrication; Male; Nonoxynol; Rectum | 2002 |
Microbicides. Raising new barriers against HIV infection.
Topics: Acrylic Resins; Anti-HIV Agents; Anti-Infective Agents; Biomedical Research; Clinical Trials as Topic; Developing Countries; Female; Gels; HIV; HIV Infections; Humans; International Cooperation; Male; Naphthalenesulfonates; Nonoxynol; Organizations, Nonprofit; Polymers; Research Support as Topic; Spermatocidal Agents | 2003 |
Nonoxynol-9 and sexually transmitted infections.
Topics: Adult; Anti-Infective Agents; Female; HIV Infections; Humans; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents | 2003 |
WHO/CONRAD technical consultation on nonoxynol-9, World Health Organization, Geneva, 9-10 October 2001: summary report.
Topics: Animals; Chlamydia Infections; Condoms; Female; Gonorrhea; HIV Infections; Humans; Lubrication; Male; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents; World Health Organization | 2002 |
Need for a true placebo for vaginal microbicide efficacy trials.
Topics: Acrylic Resins; Anti-Infective Agents, Local; Clinical Trials as Topic; Drug Combinations; Female; HIV Infections; HIV-1; Humans; Nonoxynol; Placebos; Polyvinyls; Risk Factors; Sex Work; Vaginosis, Bacterial | 2003 |
Rectal use of nonoxynol-9 among men who have sex with men.
Topics: Administration, Rectal; Adolescent; Adult; Age Factors; California; Condoms; Cross-Sectional Studies; Drug Utilization; Health Knowledge, Attitudes, Practice; HIV Infections; Homosexuality, Male; Humans; Infectious Disease Transmission, Vertical; Male; Nonoxynol; Risk Factors; Sexual Behavior; Spermatocidal Agents | 2003 |
Nonoxynol-9 ineffective in preventing HIV infection.
Topics: HIV Infections; Humans; Nonoxynol; Spermatocidal Agents; World Health Organization | 2003 |
Nonoxynol-9 ineffective in preventing HIV infection.
Topics: Female; HIV Infections; Humans; Male; Nonoxynol; Spermatocidal Agents; Treatment Failure | 2002 |
Labels issued for spermicide.
Topics: Drug Labeling; HIV Infections; Humans; Nonoxynol; Spermatocidal Agents; United States; United States Food and Drug Administration | 2003 |
Planned Parenthood drops condoms.
Topics: Condoms; HIV Infections; Humans; Male; Nonoxynol; Sexually Transmitted Diseases; Surface-Active Agents; United States | 2002 |
Disruption of the upper female reproductive tract epithelium by nonoxynol-9.
Topics: Administration, Intravaginal; Animals; Disease Models, Animal; Epithelium; Female; HIV Infections; Mice; Mice, Inbred Strains; Nonoxynol; Spermatocidal Agents; Uterus | 2003 |
Marvellous microbicides. Intravaginal gels could save millions of lives, but first someone has to prove that they work...
Topics: Acquired Immunodeficiency Syndrome; Administration, Intravaginal; Africa South of the Sahara; Anti-Infective Agents, Local; Clinical Trials as Topic; Cultural Characteristics; Female; Foundations; HIV Infections; Humans; Nonoxynol; Research Design; Research Support as Topic; Safe Sex; Treatment Failure | 2004 |
Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.
Topics: Animals; Anti-Infective Agents, Local; Benzalkonium Compounds; Biomarkers; Cervix Mucus; Epithelial Cells; Female; HIV Infections; HIV-1; Interleukin-1; Interleukin-6; Interleukin-8; Interleukins; Nonoxynol; Predictive Value of Tests; Rabbits; Sodium Dodecyl Sulfate; Sperm Motility; Spermatocidal Agents; Surface-Active Agents; Vagina | 2004 |
Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs.
Topics: Biopsy; Epithelium; HIV Infections; Humans; Lubrication; Male; Nonoxynol; Rectum; Sexual Behavior; Sexually Transmitted Diseases | 2004 |
Preclinical assessment of the proinflammatory potential of microbicide candidates.
Topics: Animals; Anti-HIV Agents; Anti-Infective Agents; Cell Line; Cervix Uteri; Cytokines; Drug Evaluation, Preclinical; Female; HIV Infections; Humans; Immunity, Mucosal; In Vitro Techniques; Inflammation; Male; NF-kappa B; Nonoxynol; Rabbits; Safety; Vagina | 2004 |
"We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.
Topics: Adolescent; Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Clinical Trials, Phase III as Topic; Counseling; Drug Evaluation; Drugs, Investigational; Female; Focus Groups; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Nonoxynol; Sex Work; Sexually Transmitted Diseases; South Africa; Spermatocidal Agents; Treatment Outcome; Vagina; Vaginal Creams, Foams, and Jellies | 2006 |
China needs safe and effective microbicides for preventing sexual transmission of HIV.
Topics: Anti-Infective Agents, Local; Benzalkonium Compounds; China; Dosage Forms; Female; HIV Infections; Humans; Mucous Membrane; Nonoxynol; Octoxynol; Spermatocidal Agents; Vagina | 2006 |
Microbicide research in developing countries: have we given the ethical concerns due consideration?
Topics: Adolescent; AIDS Vaccines; Anti-HIV Agents; Biomedical Research; Cellulose; Clinical Trials, Phase III as Topic; Condoms; Developing Countries; Ethics Committees, Research; Ethics, Research; Female; Health Services Accessibility; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Male; Moral Obligations; Nonoxynol; Pregnancy; Pregnancy Complications, Infectious; Research Design; Research Personnel; Research Subjects; Risk Assessment; Sexual Partners; South Africa; Vulnerable Populations | 2007 |
Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule.
Topics: Condoms; Contraceptive Agents; Drug Labeling; Female; HIV Infections; Humans; Male; Nonoxynol; Nonprescription Drugs; Sexually Transmitted Diseases; Spermatocidal Agents; United States | 2007 |
Nonoxynol-9 does not protect against HIV.
Topics: Adverse Drug Reaction Reporting Systems; Drug Labeling; Female; HIV Infections; HIV-1; Humans; Internet; Male; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents; United States; United States Food and Drug Administration | 2008 |
Women: absent term in the AIDS research equation.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Infective Agents; Cervix Uteri; Developing Countries; Female; HIV; HIV Infections; Humans; Male; Nonoxynol; Research; Risk Factors; Sex Distribution; Sexual Behavior; Sexually Transmitted Diseases; Vagina | 1995 |
The potential of nonoxynol-9 for the prevention of HIV infection reconsidered.
Topics: Female; HIV Infections; Humans; Nonoxynol | 1995 |
Nonoxynol-9: the need for policy in the face of uncertainty.
Topics: Female; Health Policy; HIV Infections; Humans; Nonoxynol | 1995 |
Scientists zero in on new HIV microbicides.
Topics: Antiviral Agents; Carrageenan; Cell Adhesion; Epithelium; Female; Gels; HIV Infections; Humans; Lymphocytes; Nonoxynol; Sexually Transmitted Diseases, Viral | 1995 |
Vaginal microbicides and prevention of HIV infection.
Topics: Animals; Antiviral Agents; Carrier State; Female; HIV Infections; HIV-1; Humans; Male; Nonoxynol; Spermatocidal Agents; Suppositories; Vagina | 1994 |
Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: application to detection of seminal antibodies after sexual intercourse.
Topics: Adolescent; Adult; Central African Republic; Coitus; Enzyme-Linked Immunosorbent Assay; Female; HIV Antibodies; HIV Infections; HIV-1; HIV-2; Humans; Immunoglobulin G; Male; Nonoxynol; Rape; Semen; Vagina; Zidovudine | 1994 |
The protective effect of nonoxynol-9 against HIV infection.
Topics: Administration, Intravaginal; Condoms; Female; HIV Infections; Humans; Nonoxynol | 1994 |
The urgent need for a vaginal microbicide in the prevention of HIV transmission.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intravaginal; Antiviral Agents; Female; HIV Infections; Humans; Nonoxynol; Suppositories | 1994 |
[Studied to test efficacy but ineffective].
Topics: Contraceptive Agents, Female; Drug Evaluation; Female; HIV Infections; HIV-1; Humans; Kenya; Nonoxynol; Sex Work; Writing | 1993 |
Barrier contraceptive use and HIV infection among high-risk women in Cameroon.
Topics: Adolescent; Adult; Cameroon; Cohort Studies; Condoms; Female; HIV Infections; Humans; Middle Aged; Nonoxynol; Prospective Studies; Risk Factors; Sex Work; Spermatocidal Agents | 1993 |
The efficacy of nonoxynol-9 from an in vitro point of view.
Topics: Antiviral Agents; Female; HIV; HIV Infections; Humans; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents | 1996 |
Nonoxynol-9 fails to protect against HIV-1.
Topics: Female; HIV Infections; HIV-1; Humans; Nonoxynol; Sex Work; Sexually Transmitted Diseases | 1997 |
The efficacy of nonoxynol-9 from an in vivo point of view.
Topics: Female; Gonorrhea; Herpes Genitalis; HIV Infections; Humans; In Vitro Techniques; Male; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents; Trichomonas Vaginitis | 1997 |
Acceptability and feasibility of a clinical trial to assess the efficacy of a microbicide-containing vaginal gel to prevent HIV infection among female sex workers in Abidjan, Côte d'Ivoire.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Cote d'Ivoire; Drug Administration Routes; Feasibility Studies; Female; Gels; HIV Infections; Humans; Nonoxynol; Patient Acceptance of Health Care; Sex Work; Spermatocidal Agents; Vagina | 1997 |
The protective effect of condoms and nonoxynol-9 against HIV infection.
Topics: Administration, Intravaginal; Binomial Distribution; Combined Modality Therapy; Condoms; Female; Follow-Up Studies; HIV Infections; Humans; Likelihood Functions; Linear Models; Nonoxynol; Risk Factors; Sex Work; Spermatocidal Agents; Suppositories | 1998 |
The protective effect of condoms and nonoxynol-9 against HIV infection: a response to Wittkowski and colleagues.
Topics: Administration, Intravaginal; Condoms; Data Collection; Female; HIV Infections; Humans; Male; Nonoxynol; Randomized Controlled Trials as Topic; Research Design; Spermatocidal Agents; Suppositories | 1999 |
Synthesis of dual function (5R,6R)- and (5S,6S)-5-bromo-6-methoxy-5,6-dihydro-AZT-5'-(para-bromophenyl methoxyalaninyl phosphate) as novel spermicidal and anti-HIV agents.
Topics: Anti-HIV Agents; Contraceptive Devices, Female; Dideoxynucleotides; Female; HIV; HIV Infections; Humans; Male; Nonoxynol; Organophosphorus Compounds; Spermatocidal Agents; Spermatozoa; Virus Replication; Zidovudine | 1999 |
The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.
Topics: Anti-HIV Agents; Cell Survival; HIV Infections; HIV-1; Humans; Male; Nonoxynol; Plant Proteins; Prospective Studies; Ribosome Inactivating Proteins, Type 1; Ribosome Inactivating Proteins, Type 2; Sexually Transmitted Diseases, Viral; Sperm Motility; Spermatocidal Agents; Spermatozoa; Staining and Labeling | 1999 |
Avoiding HIV transmission: women need more options.
Topics: Adult; Anti-Infective Agents, Local; Benzalkonium Compounds; Disease Transmission, Infectious; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nonoxynol; Pregnancy; Pregnancy Complications, Infectious; Spermatocidal Agents | 1999 |
Microbicides: ideas flourish, money to follow?
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Bacterial Proteins; Buffers; Carrier Proteins; Dextran Sulfate; Disease Transmission, Infectious; Female; HIV Infections; Humans; Male; Nonoxynol; Surface-Active Agents; Vaginal Creams, Foams, and Jellies | 2000 |
Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.
Topics: Antiviral Agents; Cell Polarity; Cells, Cultured; Cervix Uteri; Culture Techniques; DNA, Viral; Epithelial Cells; Female; Gramicidin; HIV Infections; HIV-1; Humans; Immunohistochemistry; Lymphocyte Activation; Microscopy, Electron; Mucous Membrane; Naphthalenesulfonates; Nonoxynol; Phytohemagglutinins; Polymers; Premenopause; Virus Replication | 2000 |
Spermicide disappoints.
Topics: Disease Transmission, Infectious; Female; HIV Infections; Humans; Nonoxynol; Spermatocidal Agents | 2000 |
Clinical research with topical microbicides as a potential HIV prevention method.
Topics: Clinical Trials, Phase III as Topic; Colposcopy; Condoms, Female; Ethics, Medical; Female; HIV Infections; Humans; Nonoxynol; Spermatocidal Agents | 2000 |
From the Centers of Disease Control and Prevention. CDC statement on study results of product containing nonoxynol-9.
Topics: Anti-Infective Agents; Centers for Disease Control and Prevention, U.S.; HIV Infections; Nonoxynol; United States | 2000 |
Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world.
Topics: Administration, Intravaginal; Anti-HIV Agents; Clinical Trials, Phase III as Topic; Condoms; Confidentiality; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Informed Consent; Male; Nonoxynol; Research Design; Sex Work; Sexual Behavior | 2000 |
Finally--international endorsement of a non-condom HIV prevention alternative.
Topics: Female; HIV Infections; Humans; Nonoxynol; Spermatocidal Agents | 1996 |
N-9 film study a blow for microbicide research.
Topics: Cameroon; Chlamydia Infections; Condoms; Female; Gonorrhea; HIV Infections; Humans; Nonoxynol; Sex Work; Sexually Transmitted Diseases; Spermatocidal Agents; United States; United States Food and Drug Administration | 1997 |
NIAID evaluates N-9 film as microbicide. National Institute of Allergy and Infectious Diseases.
Topics: Anti-Infective Agents; Contraceptive Agents, Female; Female; HIV Infections; Humans; Nonoxynol; Sexually Transmitted Diseases | 1997 |
'Ideal' microbicide may be best form of protection.
Topics: Administration, Intravaginal; Anti-HIV Agents; Cameroon; Condoms; Female; HIV Infections; Humans; Kenya; Nonoxynol; Sex Work; Sexually Transmitted Diseases, Viral; Spermatocidal Agents; Suppositories | 1999 |
The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission.
Topics: Adult; Cell Line, Transformed; Cervix Uteri; Chemokines; Cytokines; Female; HIV Infections; HIV-1; Humans; Inflammation Mediators; Interleukin-1; Middle Aged; NF-kappa B; Nonoxynol; Risk Factors; Therapeutic Irrigation; Tumor Cells, Cultured; Vagina; Vaginitis | 2001 |
'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Cell Line; Dextrins; Female; Gramicidin; HIV Infections; HIV-1; Humans; Macaca; Microbial Sensitivity Tests; Naphthalenesulfonates; Nonoxynol; Polymers; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus | 2001 |
Awareness and use of untested barrier methods by HIV-seropositive gay and bisexual men.
Topics: Bisexuality; Condoms; Health Knowledge, Attitudes, Practice; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Interviews as Topic; Male; New York City; Nonoxynol; Safe Sex; San Francisco; Socioeconomic Factors; Spermatocidal Agents; United States | 2001 |
Microbicide trial highly disappointing.
Topics: Anti-Infective Agents; Clinical Trials as Topic; HIV Infections; Humans; Nonoxynol; Placebos; Sex Work; Sexual Partners | 2000 |
Nonoxynol-9 or Frankenstein?
Topics: Controlled Clinical Trials as Topic; Female; HIV Infections; Humans; Male; Nonoxynol; Placebos; Spermatocidal Agents | 2001 |
Safety and efficacy of nonoxynol-9 questioned.
Topics: Clinical Trials as Topic; Female; HIV Infections; Humans; Nonoxynol; Risk Factors; Sex Work; Spermatocidal Agents; Treatment Outcome; Vagina; World Health Organization | 2000 |
Use of 'anti-HIV' spermicide may increase infection risk.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Male; Nonoxynol; Rectum; Spermatocidal Agents; Vagina | 2002 |
Spermicides for controlling the spread of HIV.
Topics: Contraceptive Agents; Contraceptive Devices, Male; HIV Infections; Humans; Nonoxynol; Polyethylene Glycols | 1992 |
Nonoxynol-9 and the reduction of HIV transmission in women.
Topics: Female; HIV Infections; Humans; Nonoxynol; Spermatocidal Agents | 1992 |
The use of spermicide containing nonoxynol-9 in the prevention of HIV infection.
Topics: HIV Infections; Humans; Nonoxynol; Polyethylene Glycols; Spermatocidal Agents | 1991 |
Efficacy of glove combinations in reducing cell culture infection after glove puncture with needles contaminated with human immunodeficiency virus type 1.
Topics: Gloves, Surgical; HIV Infections; HIV-1; Humans; Latex; Models, Biological; Needlestick Injuries; Nonoxynol; Polyethylene Glycols; Polymers; Spermatocidal Agents | 1991 |
[Nonoxynol-9 in a perforated condom protects against HIV infection].
Topics: Contraceptive Devices, Male; Female; HIV Infections; Humans; Male; Nonoxynol; Polyethylene Glycols; Spermatocidal Agents | 1991 |
Evaluation of the amount of nonoxynol available in condoms for the inhibition of HIV using a method based on HPLC.
Topics: Biological Availability; Chromatography, High Pressure Liquid; Contraceptive Devices, Male; HIV Infections; Nonoxynol; Polyethylene Glycols; Spermatocidal Agents | 1990 |
A proposal for slowing HIV contagion among Africans.
Topics: Adolescent; Adult; Africa; Black People; Gels; HIV Infections; Humans; Male; Middle Aged; Nonoxynol; Polyethylene Glycols; Spermatocidal Agents | 1990 |